The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Servier and Aqemia announced the extension of their new-molecule discovery collaboration on an undruggable therapeutic target in immuno-oncology.
read more
Orchard Therapeutics announced the FDA cleared its Investigational New Drug (IND) application for OTL-203, a hematopoietic stem cell (HSC) gene ...
read more
Alvotech and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced that the FDA accepted for review a Biologics ...
read more
UCB announced that the FDA accepted the company's filing to review a Biologic License Application (BLA) for its investigational treatment ...
read more
PhoreMost Ltd., has triggered a milestone payment in its multi-project target discovery collaboration with Boehringer Ingelheim. This was achieved by ...
read more
Wednesday, January 04, 2023
Checkpoint Therapeutics announced the submission of a Biologics License Application (BLA) to the FDA for the approval of cosibelimab, an ...
read more
Tuesday, January 03, 2023
Blacksmith Medicines, Inc. and Forge Therapeutics have signed a definitive merger agreement to leverage their combined chemistry platforms, creating a...
read more
Thursday, December 29, 2022
Harm Reduction Therapeutics (HRT), Inc., a 501(c)(3) nonprofit pharmaceutical company whose mission is to prevent opioid overdose deaths by making ...
read more
Friday, December 16, 2022
Now in its 20th year! The bioindustry's most in-depth, global benchmarking and analysis study: Your input is important as we benchmark current global ...
read more
Thursday, December 15, 2022
AstraZeneca and MSD announced that the FDA informed AstraZeneca that it will extend the Prescription Drug User Fee Act (PDUFA) date by three months to...
read more
Tuesday, December 13, 2022
ADMA Biologics, Inc. announced the FDA approval for its supplemental Biologics License Applications (BLAs) for both ASCENIV and BIVIGAM to now include...
read more
Monday, December 12, 2022
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a Biologics License Application (BLA) to the FDA for talquetamab...
read more
Monday, December 12, 2022
Pfizer Canada ULC and BioNTech SE announced that Health Canada has authorized COMIRNATY® Original & Omicron BA.4/BA.5 as a 10-µg booster dose for ...
read more
Monday, December 12, 2022
The U.S. Pharmacopeia (USP) announced the opening of the USP Advanced Manufacturing Technology Lab in Richmond, Virginia as part of its launch of a ...
read more
Thursday, December 08, 2022
Moleculin Biotech announced that the FDA granted Fast Track designation of WP1122 for the treatment of Glioblastoma Multiforme ("GBM").
read more